Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-020627
Filing Date
2023-05-10
Accepted
2023-05-10 16:47:10
Documents
99
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q orgo-20230331.htm   iXBRL 10-Q 2298144
2 EX-10.1 orgo-ex10_1.htm EX-10 92854
3 EX-31.1 orgo-ex31_1.htm EX-31 19532
4 EX-31.2 orgo-ex31_2.htm EX-31 20027
5 EX-32.1 orgo-ex32_1.htm EX-32 21684
6 GRAPHIC img118511161_0.jpg GRAPHIC 7100
7 GRAPHIC img118511161_1.jpg GRAPHIC 10127
8 GRAPHIC img118511161_2.jpg GRAPHIC 4315
9 GRAPHIC img118511161_3.jpg GRAPHIC 4191
10 GRAPHIC img118511161_4.jpg GRAPHIC 16309
  Complete submission text file 0000950170-23-020627.txt   10056619

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT orgo-20230331_lab.xml EX-101.LAB 500487
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT orgo-20230331_cal.xml EX-101.CAL 59535
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT orgo-20230331_pre.xml EX-101.PRE 411569
14 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT orgo-20230331.xsd EX-101.SCH 68084
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT orgo-20230331_def.xml EX-101.DEF 264673
93 EXTRACTED XBRL INSTANCE DOCUMENT orgo-20230331_htm.xml XML 2063836
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37906 | Film No.: 23907309
SIC: 2834 Pharmaceutical Preparations